Research
What research is being done for pancreatic cancer treatments and screenings today? The next life-saving treatment for the disease may be on the horizon. These articles highlight the latest in pancreatic cancer research.
367 Articles

mRNA Vaccine Shows Sustained Immune Activity in Small Patient Group
Dr. Vinod Balachandran reports notable antitumor response in about half to the patients in his mRNA vaccine clinical trial.

Pancreatic Cancer Research Highlights from ASCO GI 2025
Read about the pancreatic cancer research highlights from the ASCO GI 2025 conference, where treatments and quality-of-life were discussed.

Vitamin C Plus Standard Chemo Improves Overall Survival
Dr. Joseph Cullen believes intravenous vitamin C can help pancreatic cancer patients and his most recent trial results back this up.

Electricity-Based Treatment Boosts Overall Survival
Dr. Vincent Picozzi is enthusiastic about the results of the PANOVA-3 trial, which uses an electricity-based technique to kill cancer cells.

A Look Back at Research in 2024
Research in 2024 focused on personally tailored treatments, countering the most difficult effects of pancreatic cancer, and clinical trials.

Using A Virus to Reach the Tumor
Dr. Tara Seery is fascinated by the potential of an oncolytic virus to make chemotherapy more effective for pancreatic cancer.

Can AI Help Detect Pancreatic Cancer Early?
Dr. Mimi Canto is leading a cross-disciplinary group of researchers who are working to use AI for early detection of pancreatic cancer.

Cachexia Research Showing Promise
Dr. Teresa Zimmers reports on the latest developments in countering cachexia in pancreatic cancer patients.

Research: The Next Generation
AACR young researchers come from all over the world, and add their perspectives to pancreatic cancer studies.

A New Approach to Overcome Drug Resistance
Dr. Despina Siolas is leading one of the sites where a new drug combination to combat the effects of KRAS mutations is under trial.

Pancreatic Cancer Pain Management a Zap Away
Dr. Yaacov Lawrence discusses the results of his clinical trial using SBRT radiotherapy for pain management of pancreatic tumors.

Targeting a KRAS Variant in Advanced Pancreatic Cancer
Researchers are testing a new drug that targets KRAS variant G12D in conjunction with different chemotherapies.

A New Combination Targeting the RAS Pathway
Researchers are testing two new drugs that target the RAS pathway, to make standard chemotherapy more effective.